Protective Effects of Atorvastatin on LPS‐Induced Testicular Damage: Modulation of Spermatogenesis via PPAR‐γ, NF‐κB, and NLRP3 Pathways
Journal of Applied Toxicology · 2025
DOI: 10.1002/jat.4851 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Applied Toxicology, 2025. Verfasst von Rania Elgohary und 2 weiteren Autor:innen. Beteiligte Einrichtung: Narcotics, Ergogenics and Poisons Department, Medical Research and Clinical Studies Institute, National Research Centre (NRC), Cairo, Egypt. Hauptthemen laut MEDLINE: Atorvastatin, NLR Family, Pyrin Domain-Containing 3 Protein, Testis, Spermatogenesis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 53 Literaturangaben.
Abstract (Originalsprache)
Male infertility represents a considerable global health issue, frequently linked to oxidative stress and inflammation‐related dysfunction of the testes. Atorvastatin (ATV), a commonly prescribed statin, has effects that extend beyond merely lowering lipid levels. Recent investigations have increasingly focused on its influence on testicular function and male fertility. This research aims to assess the protective effects of ATV against testicular injury induced by lipopolysaccharide (LPS). Mice were subjected to daily administration of LPS (250 μg/kg; i.p.) for a duration of 7 days. Concurrently, ATV (25 and 50 mg/kg; orally) was administered daily alongside LPS treatment, while a control group received normal saline. ATV was found to elevate testosterone and 5α‐dihydrotestosterone (DHT) levels, reduce oxidative stress by lowering malondialdehyde (MDA) levels and increasing glutathione (GSH) and Nrf2 levels. Additionally, it mitigated inflammation by downregulating tumor necrosis factor‐alpha (TNF‐α), nuclear factor‐kappa B (NF‐κB), MAPK/ERK, and the NLRP3 inflammasome. Moreover, ATV upregulates peroxisome proliferator‐activated receptor gamma (PPARγ), which is essential for cellular metabolism and immune regulation. The findings indicate that ATV possesses significant protective effects against LPS‐induced testicular damage by alleviating oxidative stress, suppressing inflammatory responses, and fostering testicular homeostasis. Its capacity to enhance spermatogenesis underscores its potential as a promising therapeutic strategy for addressing male infertility.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Narcotics, Ergogenics and Poisons Department, Medical Research and Clinical Studies Institute, National Research Centre (NRC), Cairo, Egypt.
- Pharmacology Department, Medical Research and Clinical Studies Institute, National Research Centre (NRC), Cairo, Egypt.
ORCID-Profile: Rania Elgohary, Abeer Salama
Zitieren
APA
Elgohary, R., El-Fadaly, A. A., & Salama, A. (2025). Protective Effects of Atorvastatin on LPS‐Induced Testicular Damage: Modulation of Spermatogenesis via PPAR‐γ, NF‐κB, and NLRP3 Pathways. Journal of Applied Toxicology. https://doi.org/10.1002/jat.4851
Vancouver
Elgohary R, El-Fadaly AA, Salama A. Protective Effects of Atorvastatin on LPS‐Induced Testicular Damage: Modulation of Spermatogenesis via PPAR‐γ, NF‐κB, and NLRP3 Pathways. Journal of Applied Toxicology. 2025. doi:10.1002/jat.4851
BibTeX
@article{Elgohary2025,
author = {Elgohary, Rania and El-Fadaly, Amany A and Salama, Abeer},
title = {Protective Effects of Atorvastatin on LPS‐Induced Testicular Damage: Modulation of Spermatogenesis via PPAR‐γ, NF‐κB, and NLRP3 Pathways},
journal = {Journal of Applied Toxicology},
year = {2025},
doi = {10.1002/jat.4851}
}
EUVIMED